NOV 11, 2015 10:12 AM PST

Diagnosing Prenatal Genetic Conditions Just Got a Little More Sensitive

WRITTEN BY: Xuan Pham
Prenatal testing has been in practice for decades, helping doctors prepare women for the births of their babies. But until non-invasive prenatal testing (NIPT) came on the market recently, some prenatal tests can be quite invasive and risky, especially for women who carry high-risk fetuses. To push NIPT technology further, a group of researchers at the University of California, San Diego School of Medicine have devised a way to expand the use of NIPT to detect smaller, subtler chromosomal abnormalities.
 
New Non-Invasive Prenatal Tests Detect Smaller Chromosomal Abnormalities

NIPT came about with the discovery of cell-free fetal DNA that’s present in the blood of the expectant mothers. By taking a blood sample from the mother, researchers could isolate DNA belonging to the baby and run a gamut of genetic tests to inform the health condition of the baby. This new platform offers many advantages over conventional methods like amniocentesis or chorionic villus sampling (CVS), which are invasive, painful, and carry a risk for miscarriage and infection. Thus far, however, NIPT has been limited to detecting large chromosomal aberrations, like whole duplication of chromosome 21 in Down Syndrome.

The research team, led by Dr. Kang Zhang, attempted to “zoom in and examine a small segment of a chromosome” by combining NIPT with semiconductor sequencing. They collected blood from 1,476 pregnant women whose ultrasounds had revealed abnormal fetal structures. The average gestational age for the pregnant women was 24 weeks. The researchers then sequenced the maternal blood using semiconductor sequencing, a form of “sequencing by synthesis” based on the release and detection of hydrogen ions. The sequencing results were validated with array comparative genomic hybridization and then compared to the conventional invasive diagnoses made for each of the women. Dr. Zhang published that this method could detect subchromosomal duplications and deletions with 94.5% sensitivity compared to the conventional methods.

While remarkable, there are several caveats to the study. First, the high sensitivity was achieved by increasing sequencing depths from 3.5 million read to 10 million reads and restricting the size of chromosomal abnormalities to greater than 1 Mb. This means that the reliability of the method is dependent on sequencing depth, which is not surprising but should be taken into consideration. Second, the researchers reported 55 false positives, of which 35 were due to maternal chromosomal abnormalities. To increase the specificity for their method, the team has to conduct additional validation tests to screen out maternal DNA contamination.

Dr. Zhang and his research team aim to improve their method to detect chromosomal abnormalities less than 1 Mb, and also at an earlier gestational age of 12 to 16 weeks. He also expressed hope that the new platform can be extended to diagnosing other conditions.

"While this study focused on cell-free DNA sequencing in pregnant women, this method could be applied more broadly to other genetic diagnoses, such as analyzing circulating tumor DNA for detection of cancer." – Dr. Kang Zhang.

As a word of caution, Dr. Zhang noted that with increased detection potential comes the increased likelihood of uncovering chromosomal aberrations of unknown clinical significance. "If our NIPT extension is put into clinical practice, great care must be taken in presenting results and providing appropriate counseling to patients," cautions Dr. Zhang. 

Watch the video to learn more about fetal DNA and NIPT!
 

Source: EurekAlert
About the Author
  • I am a human geneticist, passionate about telling stories to make science more engaging and approachable. Find more of my writing at the Hopkins BioMedical Odyssey blog and at TheGeneTwist.com.
You May Also Like
MAY 04, 2018
Clinical & Molecular DX
MAY 04, 2018
New Blood Test Detects Peanut Allergy with 98% Specificity
A new blood test trumps traditional diagnostic methods for determining peanut allergy, the most common allergy for children. From the Medical Research Coun...
JUN 12, 2018
Cell & Molecular Biology
JUN 12, 2018
Loss of Brain Lesions may Indicate Worsening MS
New research could help doctors determine how severe a case of multiple sclerosis will become....
JUN 27, 2018
Clinical & Molecular DX
JUN 27, 2018
Are High-Strength MRIs Releasing Mercury from Dental Fillings?
A super strong MRI approved by the U.S. Food and Drug Administration (FDA) may be releasing dangerous amounts of mercury from tooth fillings. From Akdeniz...
JUL 13, 2018
Genetics & Genomics
JUL 13, 2018
Detecting Leukemia Before it Starts Growing
Researchers have found ways to identify people who may develop an aggressive type of blood cancer while they are still healthy....
AUG 16, 2018
Clinical & Molecular DX
AUG 16, 2018
Nanotech patch makes light-up medical tests 100x brighter
Researchers have developed a high-tech fix that uses metal nanostructures to increase the fluorescence intensity by 100 times in diagnostic tests. It&rsquo...
AUG 22, 2018
Clinical & Molecular DX
AUG 22, 2018
New Clinical Assay Useful For Urothelial Cancer
U.S. Food and Drug Administration (FDA) has now approved a pharmDx assay called ‘Dako PD-L1 IHC 22C3’ by Agilent Technologies Inc. for use in u...
Loading Comments...